There were 372 press releases posted in the last 24 hours and 424,661 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image